TXNIP and coronary artery disorder: After adjusting for covariates, ancova models showed that CAD patients had higher levels of TXNIP mRNA expression (1.20 ± 0.28 versus 1.06 ± 0.28, P = 0.001), plasma TXNIP (289.3 ± 23.0 pg/ml versus 274.1 ± 23.0 pg/ml, P < 0.001) and MDA (1.76 ± 0.35 μmol/l versus 1.61 ± 0.32 μmol/l, P = 0.011) than the control group (Table S7).